JeffreyKKlotzMD

Oncology • Laurinburg, NC

Hematologic Oncology

Physician

Join to view full profile

Dr. Klotz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Klotz's full profile

Already have an account?

Office
Scotland Cancer Treatment Center - Duke Cancer Network
500 Lauchwood Drive
Laurinburg, NC 28352
Phone+1 910-291-7630

Fax+1 910-291-7635
Is this information wrong?

Summary

I am a community hematologist / oncologist with the Duke Cancer Network since 2017. I served in the United States Army for 24 years as an internist and hematologist/oncologist before joining the Duke Cancer Network.

Education & Training

National Capital ConsortiumFellowship, Hematology and Medical Oncology, 2009 - 2012
San Antonio Uniformed Services Health Education ConsortiumResidency, Internal Medicine, 1997 - 2000
UniforMed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 1997

Certifications & Licensure

NC State Medical License 2015 - 2024
TX State Medical License 2007 - 2016
LA State Medical License 1998 - 2007
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

COL Robert H. Moser Award Army Chapter American College of Physicians, 2003

Publications & Presentations

PubMed

5 citations
Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia.
Prachi Jain, Jeffrey K. Klotz, Neil Dunavin, Kit Lu, Eleftheria Koklanaris, Debbie Draper, Jeanine Superata, Fariba Chinian, Quan Yu, Keyvan Keyvanfar, Susan Wong, Paw...> ;Leukemia Research Reports. 2017 Jan 1
5 citations
Radiation exposure from diagnostic procedures following allogeneic stem cell transplantation – How much is acceptable?
Minoo Battiwalla, Farhad Fakhrejahani, Natasha A. Jain, Jeffrey K. Klotz, Priyanka A. Pophali, Debbie Draper, Janice Haggerty, Zachariah A. McIver, James Jelinek, Kamn...> ;Hematology. 2014 Jun 18
70 citations
Bone marrow mesenchymal stromal cells to treat tissue damage in allogeneic stem cell transplant recipients: correlation of biological markers with clinical responses.
Fang Yin, Minoo Battiwalla, Sawa Ito, Xingmin Feng, Fariba Chinian, J. Joseph Melenhorst, Eleftheria Koklanaris, Marianna Sabatino, David F. Stroncek, Leigh Samsel, Je...> ;Stem Cells. 2014 May 1
24 citations
Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events
Priyanka A. Pophali, Jeffrey K. Klotz, Sawa Ito, Natasha A. Jain, Eleftheria Koklanaris, Robert Q. Le, Christopher S. Hourigan, Bipin N. Savani, Kamna Chawla, Sujata M...> ;Experimental Hematology. 2014 Feb 1
11 citations
Repair of Impaired Pulmonary Function Is Possible in Very-Long-Term Allogeneic Stem Cell Transplantation Survivors
Natasha A. Jain, Priyanka A. Pophali, Jeffrey K. Klotz, Sawa Ito, Eleftheria Koklanaris, Kamna Chawla, Christopher S. Hourigan, Nicole Gormley, Bipin N. Savani, Austin...> ;Biology of Blood and Marrow Transplantation. 2014 Feb 1
Join now to see all